Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Upcoming Updates
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(33)
•••
Post by Hideawayon Dec 01, 2021 12:23pm
220 Views
Post# 34185471

Upcoming Updates

Upcoming Updates We are scheduled to receive a couple of updates by end of the month.One for the phase 2 basket trials and another re the ovarian cancer submission to FDA for phase 2 clinical study protocol.
I hope that our expectations will be met but timeliness has been an issue in the past.
The shares have not exhibited much confidence in IMV.Hope for the best.
Board is awful quiet.Anyone have some encouraging thoughts?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities